Previous Article | Next Article 
Journal of Clinical Microbiology, April 2001, p. 1501-1505, Vol. 39, No. 4
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.4.1501-1505.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Evaluation of Mycobacteria Growth Indicator Tube
for Direct and Indirect Drug Susceptibility Testing of
Mycobacterium tuberculosis from Respiratory Specimens in a
Siberian Prison Hospital
Vera
Goloubeva,1
Maryvonne
Lecocq,2
Piotr
Lassowsky,2
Francine
Matthys,3
Françoise
Portaels,4 and
Ivan
Bastian4,5,*
Bacteriology Laboratory, Colony
33,1 and Médecins Sans
Frontières,2 Mariinsk, Siberia;
Médecins Sans Frontières,
Brussels,3 and Mycobacteriology Unit,
Institute of Tropical Medicine, Antwerp,4
Belgium; and Institute of Medical and Veterinary Science,
Adelaide, Australia5
Received 22 September 2000/Returned for modification 29 December
2000/Accepted 29 January 2001
The manual Mycobacteria Growth Indicator Tube (MGIT) method was
evaluated for performing direct and indirect drug susceptibility testing (DST) of Mycobacterium tuberculosis for isoniazid
and rifampin on 101 strongly smear-positive sputum specimens in a Siberian prison hospital. Using the indirect method of proportion (MOP)
as the "gold standard," the accuracies of isoniazid and rifampin
susceptibility testing by the direct MGIT system were 97.0 and 94.1%,
respectively. The accuracy of the indirect MGIT system was 98.0% for
both drugs. The turnaround times from specimen processing to reporting
of the DST results ranged between 4 and 23 (mean, 9.2) days by the
direct MGIT method, 9 and 30 (mean, 15.3) days by the indirect MGIT
method, and 26 and 101 (mean, 59.6) days by the indirect MOP. MGIT
appears to be a reliable, rapid, and convenient method for performing
direct and indirect DSTs in low-resource settings, but further studies
are required to refine the direct DST protocol. Cost is the only factor
prohibiting widespread implementation of MGIT.
*
Corresponding author. Mailing address: Institute of
Medical & Veterinary Science, P.O. Box 14, Rundle Mall, Adelaide, SA
5000, Australia. Phone: 61-8-8222-3291. Fax: 61-8-8222-3543. E-mail: ivan.bastian{at}imvs.sa.gov.au.
Journal of Clinical Microbiology, April 2001, p. 1501-1505, Vol. 39, No. 4
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.4.1501-1505.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Affolabi, D., Odoun, M., Sanoussi, N., Martin, A., Palomino, J. C., Kestens, L., Anagonou, S., Portaels, F.
(2008). Rapid and Inexpensive Detection of Multidrug-Resistant Mycobacterium tuberculosis with the Nitrate Reductase Assay Using Liquid Medium and Direct Application to Sputum Samples. J. Clin. Microbiol.
46: 3243-3245
[Abstract]
[Full Text]
-
Shiferaw, G., Woldeamanuel, Y., Gebeyehu, M., Girmachew, F., Demessie, D., Lemma, E.
(2007). Evaluation of Microscopic Observation Drug Susceptibility Assay for Detection of Multidrug-Resistant Mycobacterium tuberculosis. J. Clin. Microbiol.
45: 1093-1097
[Abstract]
[Full Text]
-
Huang, T.-S., Liu, Y.-C., Tu, H.-Z., Sy, C.-L., Chen, Y.-S., Chen, B.-C.
(2007). Rapid Purity Check Method for Susceptibility Testing of M. tuberculosis Complex with the MGIT 960 System. Annals of Clinical & Laboratory Science
37: 323-329
[Abstract]
[Full Text]
-
Nateche, F., Martin, A., Baraka, S., Palomino, J. C., Khaled, S., Portaels, F.
(2006). Application of the resazurin microtitre assay for detection of multidrug resistance in Mycobacterium tuberculosis in Algiers.. J Med Microbiol
55: 857-860
[Abstract]
[Full Text]
-
Somoskovi, A., Clobridge, A., Larsen, S. C., Sinyavskiy, O., Surucuoglu, S., Parsons, L. M., Salfinger, M.
(2006). Does the MGIT 960 System Improve the Turnaround Times for Growth Detection and Susceptibility Testing of the Mycobacterium tuberculosis Complex?. J. Clin. Microbiol.
44: 2314-2315
[Full Text]
-
Rusch-Gerdes, S., Pfyffer, G. E., Casal, M., Chadwick, M., Siddiqi, S.
(2006). Multicenter Laboratory Validation of the BACTEC MGIT 960 Technique for Testing Susceptibilities of Mycobacterium tuberculosis to Classical Second-Line Drugs and Newer Antimicrobials.. J. Clin. Microbiol.
44: 688-692
[Abstract]
[Full Text]
-
Musa, H. R., Ambroggi, M., Souto, A., Angeby, K. A. K.
(2005). Drug Susceptibility Testing of Mycobacterium tuberculosis by a Nitrate Reductase Assay Applied Directly on Microscopy-Positive Sputum Samples. J. Clin. Microbiol.
43: 3159-3161
[Abstract]
[Full Text]
-
Huang, T.-S., Lee, S. S.-J., Tu, H.-Z., Huang, W.-K., Chen, Y.-S., Huang, C.-K., Wann, S.-R., Lin, H.-H., Liu, Y.-C.
(2004). Use of MGIT 960 for rapid quantitative measurement of the susceptibility of Mycobacterium tuberculosis complex to ciprofloxacin and ethionamide. J Antimicrob Chemother
53: 600-603
[Abstract]
[Full Text]
-
Abate, G., Aseffa, A., Selassie, A., Goshu, S., Fekade, B., WoldeMeskal, D., Miorner, H.
(2004). Direct Colorimetric Assay for Rapid Detection of Rifampin-Resistant Mycobacterium tuberculosis. J. Clin. Microbiol.
42: 871-873
[Abstract]
[Full Text]
-
Syre, H., Phyu, S., Sandven, P., Bjorvatn, B., Grewal, H. M. S.
(2003). Rapid Colorimetric Method for Testing Susceptibility of Mycobacterium tuberculosis to Isoniazid and Rifampin in Liquid Cultures. J. Clin. Microbiol.
41: 5173-5177
[Abstract]
[Full Text]
-
Bemer, P., Palicova, F., Rusch-Gerdes, S., Drugeon, H. B., Pfyffer, G. E.
(2002). Multicenter Evaluation of Fully Automated BACTEC Mycobacteria Growth Indicator Tube 960 System for Susceptibility Testing of Mycobacterium tuberculosis. J. Clin. Microbiol.
40: 150-154
[Abstract]
[Full Text]
-
Bastian, I., Rigouts, L., Palomino, J. C., Portaels, F.
(2001). Kanamycin Susceptibility Testing of Mycobacterium tuberculosis Using Mycobacterium Growth Indicator Tube and a Colorimetric Method. Antimicrob. Agents Chemother.
45: 1934-1936
[Abstract]
[Full Text]